Featured news

FINANCIAL SUMMARY Net sales for the fourth quarter amounted to TSEK 75 (674) and for the full year to TSEK 1,443 (1,555) The operating loss for the quarter amounted to TSEK -35,638 (-13,251) and for the full year to TSEK -69,963 (-50,850). Operating loss was affected by write-downs of tangible and intangible assets during the quarter as well as for the full year totaling TSEK 14,523 (0) Loss after tax for the quarter amounted to

Nanologica’s Chinese distributor Yunbo Technologies has made a first call-off against the agreement previously signed for the delivery of silica worth USD 14 million over a six-year period. In connection with Nanologica’s start of large-scale production of silica in 2019, a supply agreement was signed with the company’s Chinese distributor Yunbo Technologies, whereby Nanologica will deliver media for preparative chromatography to a value of approximately USD 14 million over a six-year period. The delivery that

NANOLOGICA RECEIVES ORDER OF PURIFICATION MEDIA WORTH APPROX. MSEK 3.6 Nanologica expands its product portfolio of purification medias for preparative chromatography and has received a trial order worth approximately MSEK 3.6 from a customer in Asia. Product development of this purification media, NLAB Siv™, has been conducted together with a customer who has a number of launched pharmaceutical products. NLAB Siv™ is a non-silica-based purification media for preparative chromatography and manufacturing takes place at a